Skip to main content

Table 4 Adjusted mean level of SUA at baseline and during exposure period

From: Comparative effect of angiotensin II type I receptor blockers on serum uric acid in hypertensive patients with type 2 diabetes mellitus: a retrospective observational study

ARB

Baseline

Exposure

p value

Mean

95% CI

Mean

95% CI

Losartan

5.18

(5.03, 5.32)

5.04

(4.90, 5.19)

0.0194*

Valsartan

5.30

(5.15, 5.45)

5.49

(5.34, 5.63)

0.0012*

Telmisartan

5.34

(5.18, 5.49)

5.47

(5.32, 5.63)

0.0253*

Candesartan

5.54

(5.43, 5.65)

5.68

(5.57, 5.79)

0.0011*

Olmesartan

5.39

(5.22, 5.56)

5.58

(5.41, 5.75)

0.0013*

  1. ARB, Angiotensin II type I receptor blocker; CI, Confidence interval. *: p < 0.05 (exposure period vs baseline, Dunnett-Hsu post-hoc analysis). Analyses were adjusted for covariates including age, sex, medical history and previous medication.
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840